4
Changes in Ownership
SUTRO BIOPHARMA, INC. Filed Acc 0001415889-24-019462
Options or other derivatives
- Chief Business Dev. Officer acquired 225,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Leyman Barbara Chief Business Dev. Officer | 2024-07-08 | Grant or award · Stock Option (Right to Buy Common Stock) | +125,000 | 125,000 | D | ||
| Leyman Barbara Chief Business Dev. Officer | 2024-07-08 | Grant or award · Restricted Stock Units (RSUs) | +100,000 | 100,000 | D | ||
Loading xslF345X05/form4-07102024_080725.xml…